APP
WST icon

Alpha Paradigm Partners’s West Pharmaceutical WST Stock Holding History

Alpha Paradigm Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-658
Closed -$199K – 651
2022
Q2 		$199K Hold
658
– – 0.08% 322
2022
Q1 		$270K Sell
658
-87
-12% -$34.1K 0.11% 289
2021
Q4 		$349K Hold
745
– – 0.14% 252
2021
Q3 		$316K Sell
745
-43
-5% -$18.1K 0.13% 257
2021
Q2 		$283K Sell
788
-388
-33% -$128K 0.11% 300
2021
Q1 		$331K Buy
1,176
+760
+183% +$218K 0.13% 236
2020
Q4 		$118K Buy
+416
New +$117K 0.04% 310

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return